Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

New synthetic technology in drug discovery

6th European Biopharma Congress

Takashi Takahashi

Yokohama University of Pharmacy, Japan

Keynote: Clin Pharmacol Biopharm

DOI: 10.4172/2167-065X-C1-027

Abstract
Automated synthesis and flow chemistry have attracted a great deal of attention in recent years because these processes improve both the reproducibility and reliability of synthesis. Development of automated synthetic procedures and storage of relevant digital data allow anyone to reproduce the same results anytime and anywhere using the same apparatus and reagents. As a result, synthetic chemists can spend more time on advanced and challenging problems. Automated synthesis and flow chemistry often enhance the safety profile of the synthetic processes. Flow chemistry is effective for the hazardous reactions using toxic reagents or high pressure gases. Herein, we report the automated synthesis of taxol, enediyne, lewisX and ketopiperazine analogues and the flow synthesis of peptides and aliphatic aldehydes.
Biography

Takashi Takahashi is a Professor of Medicinal Chemistry at Yokohama University of Pharmacy, Japan. He has his expertise in Natural Products and Medicinal Chemistry of drug development.

E-mail: ttak@yok.hamayaku.ac.jp

 

Top